What’s New!
Establishment of EDBI’s new Growth IPO Fund
Boosting Equity Financing for High-Growth Enterprises
Homegrown Mooring Solutions Provider Mooreast Holdings IPOs on SGX Catalist
WalkMe Announces Launch of Initial Public Offering
SAN FRANCISCO, June 7, 2021 /PRNewswire/ — WalkMe Ltd. (“WalkMe”), a leading provider of digital adoption solutions, today announced the launch of its initial public offering of 9,250,000 of its ordinary shares. The underwriters will have a 30-day option to purchase up to an additional 1,387,500 ordinary shares at the initial public offering price, less underwriting discounts and commissions.
- 7 Jun 2021
WEFOX CLOSES RECORD SERIES C FUNDING ROUND FOR INSURTECH – US$650m, MARKET VALUE US$3bn
wefox, the Berlin-based digital insurance company has raised a record US$650 million for its Series C funding round led by Target Global, resulting in a post-money valuation of US$3 billion.
- 1 Jun 2021
Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic Codes for New Medicines Through Machine Learning and Next-Generation Combinatorial Genetics
MAY 26, 2021 – SINGAPORE & SAN CARLOS, Calif.–Engine Biosciences (“Engine”) today announced the successful completion of an oversubscribed $43 million Series A funding round. Engine identifies errors in the complex genetic codes of diseases, fixing them with precise therapeutic solutions.
- 26 May 2021
Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings
SINGAPORE, May 26, 2021 – Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation, Singapore-based global investor EDBI, a reputable, long-term institutional investor, and other sophisticated investors.
- 26 May 2021
Hummingbird Bioscience Raises US$125 Million in Series C Financing
SINGAPORE, May 17, 2021 – Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes, today announced the close of its US$125 million Series C financing round.
- 17 May 2021
Cityneon Raises S$235 Million; Well Positioned For Next Growth Chapter
Singapore, 21st April 2021 – Cityneon Holdings (“Cityneon”, the “Company”/collectively with its subsidiaries, the “Group”) raised S$235 million in the most recent round of private funding. The latest round of funding adds seasoned investors to Cityneon’s already strong stable of shareholders.
- 21 Apr 2021
Digitally transforming Southeast Asia’s automotive sector with AI and Technology
2020 was a watershed year for Southeast Asia’s automotive sales. During the pandemic, more people considered buying personal vehicles as a safer option to get around. Concurrently, more consumers were interested in purchasing used vehicles as value-for-money options and doing so through online platforms.
- 15 Apr 2021
ImmunoScape Raises $14M To Advance Deep Immunomics Platform for High-Dimensional Immune Profiling and Drug Discovery
SINGAPORE and SAN DIEGO – April 14, 2021 – ImmunoScape, a biotech company with an immunomics-based technology platform that provides novel insights into the human immune system, today announced it has completed a $14 million fundraising round co-led by new investor EDBI together with existing investors Anzu Partners and University of Tokyo Edge Capital Partners (UTEC).
- 14 Apr 2021
AvePoint Launches EduTech To Improve Higher Education Technology
SINGAPORE, Feb. 28, 2021 – AvePoint, Inc., one of the largest Microsoft 365 data management solutions providers, announced today the global launch of AvePoint EduTech.
- 28 Feb 2021
Enhancing the development of the ASEAN markets and accelerating global market expansion for Chinese biopharma companies
Take a deep dive into the ASEAN biopharmaceutical landscape
- 20 Dec 2020